A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT07083193 · RECRUITING
Trial details
- NCT number
- NCT07083193
- Sponsor
- Accro Bioscience (Suzhou) Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-20
- Primary completion
- 2026-09-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.